Lightning Round OT: Tekelec, Jazz Pharma and More

Wednesday, 16 Dec 2009 | 6:58 PM ET

Jazz Pharmaceuticals : Cramer likes JAZZ as a speculation biotech play.

Lightning Round OT
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

Immunogen : Cramer is bullish on IMGN after the company’s strong showing at the recent American Society of Hematology conference.

Tekelec : TKLC is a buy, Cramer said, especially on its recent pullback. He likes it as a play on the growth in the mobile Internet space.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change


Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.